General Information of the Compound
| Compound ID |
CP0512065
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[[(3R)-2,3,6,7,8,9-hexahydrobenzo[g][1,4]benzodioxin-3-yl]methyl]-2-(2-methoxynaphthalen-1-yl)oxyethanamine;hydrochloride
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H29NO4
|
||||||||||||||||||
| Molecular Weight |
419.521
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc2ccccc2c1OCCNC[C@@H]1COc2cc3CCCCc3cc2O1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H29NO4.ClH/c1-28-23-11-10-18-6-4-5-9-22(18)26(23)29-13-12-27-16-21-17-30-24-14-19-7-2-3-8-20(19)15-25(24)31-21;/h4-6,9-11,14-15,21,27H,2-3,7-8,12-13,16-17H2,1H3;1H/t21-;/m1./s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
BXAUNYRCMJYSAD-ZMBIFBSDSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01089, Alpha-1A adrenergic receptor
Protein ID: PT01007, Alpha-1B adrenergic receptor
Protein ID: PT01004, Alpha-1D adrenergic receptor